What companies are RCUS's competitors?

Arcus Biosciences, Inc. (RCUS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does RCUS compare to its peers?

The peer comparison table on this page shows Arcus Biosciences, Inc. (RCUS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does RCUS operate in?

Arcus Biosciences, Inc. (RCUS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

RCUS

Arcus Biosciences, Inc.

NYSE·Biotechnology · Healthcare

$18.54$0.82−4.24%

Market cap$2.33B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About RCUS

What companies are RCUS's competitors?: Arcus Biosciences, Inc. (RCUS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RCUS compare to its peers?: The peer comparison table on this page shows Arcus Biosciences, Inc. (RCUS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RCUS operate in?: Arcus Biosciences, Inc. (RCUS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

RCUS

Arcus Biosciences, Inc.

NYSE·Biotechnology · Healthcare

$18.54$0.82−4.24%

Market cap$2.33B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


IBRXIBRXImmunityBio, Inc.	ImmunityBio, Inc.	$8.22	$8.7B
COGTCOGTCogent Biosciences, Inc.	Cogent Biosciences, Inc.	$31.21	$5.4B
LQDALQDALiquidia Corporation	Liquidia Corporation	$42.65	$3.8B
DNLIDNLIDenali Therapeutics Inc.	Denali Therapeutics Inc.	$18.41	$2.9B
VRDNVRDNViridian Therapeutics, Inc.	Viridian Therapeutics, Inc.	$22.37	$2.5B
BEAMBEAMBeam Therapeutics Inc.	Beam Therapeutics Inc.	$24.05	$2.5B
AGIOAGIOAgios Pharmaceuticals, Inc.	Agios Pharmaceuticals, Inc.	$37.00	$2.2B
ETNBETNB89bio, Inc.	89bio, Inc.	$14.84	$2.2B
GLPGGLPGGalapagos N.V.	Galapagos N.V.	$27.98	$1.8B
OCULOCULOcular Therapeutix, Inc.	Ocular Therapeutix, Inc.	$6.50	$1.4B

Frequently Asked Questions About RCUS

What companies are RCUS's competitors?: Arcus Biosciences, Inc. (RCUS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RCUS compare to its peers?: The peer comparison table on this page shows Arcus Biosciences, Inc. (RCUS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RCUS operate in?: Arcus Biosciences, Inc. (RCUS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.